Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Publication year range
1.
Pathologica ; 98(2): 164-6, 2006 Apr.
Article in Italian | MEDLINE | ID: mdl-16929792

ABSTRACT

Adenomatoid tumour is a neoplastic process of discussed origin, but the immunohistochemical phenotype leads a mesothelial derivation. The preferential site of origin is the genital apparatus of both sexes, however extragenital cases have been described. The histological pattern varies from tubular formation, to solid growth, to cystic areas. In the present report we described a case of Adenomatoid tumour of the uterus body in a 46 years old patient.


Subject(s)
Adenomatoid Tumor/pathology , Uterine Neoplasms/pathology , Actins/analysis , Adenomatoid Tumor/chemistry , Adenomatoid Tumor/diagnosis , Calbindin 2 , Diagnosis, Differential , Female , Humans , Immunoenzyme Techniques , Keratins/analysis , Leiomyoma/diagnosis , Middle Aged , Neoplasm Proteins/analysis , S100 Calcium Binding Protein G/analysis , Staining and Labeling , Uterine Neoplasms/chemistry , Uterine Neoplasms/diagnosis
2.
Br J Cancer ; 94(4): 578-85, 2006 Feb 27.
Article in English | MEDLINE | ID: mdl-16465194

ABSTRACT

Tumours ferment glucose to lactate even in the presence of oxygen (aerobic glycolysis; Warburg effect). The pentose phosphate pathway (PPP) allows glucose conversion to ribose for nucleic acid synthesis and glucose degradation to lactate. The nonoxidative part of the PPP is controlled by transketolase enzyme reactions. We have detected upregulation of a mutated transketolase transcript (TKTL1) in human malignancies, whereas transketolase (TKT) and transketolase-like-2 (TKTL2) transcripts were not upregulated. Strong TKTL1 protein expression was correlated to invasive colon and urothelial tumours and to poor patients outcome. TKTL1 encodes a transketolase with unusual enzymatic properties, which are likely to be caused by the internal deletion of conserved residues. We propose that TKTL1 upregulation in tumours leads to enhanced, oxygen-independent glucose usage and a lactate-based matrix degradation. As inhibition of transketolase enzyme reactions suppresses tumour growth and metastasis, TKTL1 could be the relevant target for novel anti-transketolase cancer therapies. We suggest an individualised cancer therapy based on the determination of metabolic changes in tumours that might enable the targeted inhibition of invasion and metastasis.


Subject(s)
Adenocarcinoma/genetics , Adenocarcinoma/physiopathology , Colonic Neoplasms/genetics , Colonic Neoplasms/physiopathology , Gene Expression Profiling , Glycolysis , Transketolase/biosynthesis , Urinary Bladder Neoplasms/genetics , Adenocarcinoma/mortality , Aged , Colonic Neoplasms/mortality , Female , Humans , Male , Middle Aged , Neoplasm Invasiveness , Neoplasm Metastasis , Predictive Value of Tests , Prognosis , Survival Analysis , Up-Regulation , Urinary Bladder Neoplasms/mortality , Urinary Bladder Neoplasms/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL